Potential Utility of Combined Salivary Calprotectin and Anti-Cyclic Citrullinated Peptide in Rheumatoid Arthritis Assessment
Misong Kim, Young Il Kim, Yeon-Ah Lee, Seung-Jae Hong · 2025
Read Potential Utility of Combined Salivary Calprotectin and Anti-Cyclic Citrullinated Peptide in Rheumatoid Arthritis Assessment by Misong Kim, Young Il Kim, Yeon-Ah Lee, Seung-Jae Hong (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12785978.txt.
Description
Misong Kim and three co-authors test whether spit can stand in for blood in checking rheumatoid arthritis, in a 2025 journal article. The illness is a long immune attack on the joints. Blood tests now in use work well but need a needle, which some patients dread.
The team took spit from 58 patients and fifty healthy adults and read two marks in it. One mark, calprotectin, rises with swelling. The other is an antibody long tied to the illness. Both ran far higher in patients. The first mark caught most cases, while the second rarely fired in health. A joint model with clinic facts split the groups with fine skill. The authors say a spit test could ease checks.
Catalog record
| CREATOR | Misong Kim, Young Il Kim, Yeon-Ah Lee, Seung-Jae Hong |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 28 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |